Durability of Respiratory Syncytial Virus Vaccine Effectiveness Among US Veterans
The study found that RSV vaccination was effective in preventing RSV illness and associated health care use but that protection decreased over 2 seasons. Reductions were most notable among immunocompromised persons, suggesting the need to review whether additional vaccine doses may benefit certain risk groups.
Authors
- Lei Yan (ORCID: https://orcid.org/0000-0002-4779-2688)
- Vyshnika Sriskantharajah
- George N. Ioannou (ORCID: https://orcid.org/0000-0003-1796-8977)
- Mihaela Aslan (ORCID: https://orcid.org/0000-0002-5041-010X)
- Kristin Berry (ORCID: https://orcid.org/0009-0000-7372-7727)
- Denise M. Hynes
- Nallakkandi Rajeevan (ORCID: https://orcid.org/0000-0002-2045-0872)
- David Bui (ORCID: https://orcid.org/0000-0003-0861-0850)
- Kristina L. Bajema (ORCID: https://orcid.org/0000-0002-3229-5590)
- Yuli Li (ORCID: https://orcid.org/0000-0003-1364-8562)
- Hung‐Mo Lin (ORCID: https://orcid.org/0000-0003-3176-6570)
- Yuan Huang
- Robert Vergun
Institutions
- Oregon State University (US)
- Oregon Health & Science University (US)
- University of Washington (US)
- Veterans Health Administration (US)
- Yale University (US)
- VA Puget Sound Health Care System (US)
- VA Portland Health Care System (US)
- Department of Veterans Affairs (AU)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1001/jamainternmed.2025.6355
- Citations
- 3
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 4.06